Introduction
NASOPHARYNGEAL CANCER
There are currently 2 standard treatment options for locoregionally advanced nasopharyngeal cancer (LA-NPC). Patients can be treated with induction chemotherapy followed by concurrent chemoradiotherapy (CCRT) or CCRT followed by adjuvant chemotherapy.Overexpression of vascular endothelial growth factor (VEGF) A has been associated with a poor prognosis for NPC.